Birzeit Pharmaceuticals Company (PEX:BPC)

Market Cap	103.03M
Revenue (ttm)	29.63M
Net Income (ttm)	5.64M
Shares Out	38.76M
EPS (ttm)	0.15
PE Ratio	18.24
Forward PE	n/a
Dividend	0.04 (1.33%)
Ex-Dividend Date	Apr 23, 2025

Volume	4,210
Average Volume	8,470
Open	3.760
Previous Close	3.750
Day's Range	3.750 - 3.760
52-Week Range	3.550 - 4.350
Beta	-0.00
RSI	48.88
Earnings Date	Aug 13, 2025

About PEX:BPC

Birzeit Pharmaceuticals Company manufactures and trades in various medicines in the Palestinian Authority. The company offers its products in various therapeutic fields comprising alimentary system, cardio-vascular system, muscolo-skeletal system, endocrines, central nervous system, genito-urinary system, obstetrics and gynecology, infections, dermatological preparations, ophthalmic drugs, respiratory system, and nutrition and metabolism, as well as ear, nose, and oropharynx. It also provides OTC products, such as multivitamins and minerals, an...

• Industry: Pharmaceutical Preparations
• Founded: 1973
• Employees: 300
• Stock Exchange: Palestine Stock Exchange
• Ticker Symbol: BPC

Financial Performance

In 2024, PEX:BPC's revenue was $40.65 million, a decrease of -5.74% compared to the previous year's $43.13 million. Earnings were $5.18 million, a decrease of -15.26%.

Financial numbers in USD